课题基金 / 基金详情

Cleavage of α-sunuclein by Neurosin (Kallikrein-6)

Cleavage of α-sunuclein by Neurosin (Kallikrein-6)
Neurosin (Kallikrein-6) 对 α-sunuclein 的裂解
批准号:
16590840
负责人:
MIZUNO Toshiki
金额:
$2.3万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005

项目摘要

项目成果

MIZUNO Toshiki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Background : Neurosin (Kallikrein-6), one of the serine proteases predominantly expressed in the central nervous system, was reported to be possible to degrade α-synuclein, a key protein for Parkinson disease. However, cleavage site of α-synuclein by neurosin has not been detected. In this study, cleavage sites of α-synuclein were identified by LC/MS/MS.Method : Degradations of wild and mutant α-synuclein by neurosin were evaluated semi-quantitatively by SDS-PAGE. Restricted fragments of α-synuclein cleaved by neurosin were examined by LC/MS/MS (Ion trap mass spectrometer ; LCQ Advatage, Themo Electron Corporation, Waltham, MA).Results : The first cleaving site of α-synuclein was Lyn80, and secondly Lyn96, Lyn97, Asp115 and Asp121 were cleaved by neurosin. A30P mutant α-synuclein was degraded slower than wild α-synuclein by neurosin.Interpretation : The dominant cleaving site of Lyn80 is the center of the NAC region, which is responsible for polymerization of the α-synuclein. Our results showed that neurosin can degrade α-synuclein and it may inhibit the polymerization of α-synuclein by cleaving the NAC region.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
Quantitative evaluation of cerebrovascular reactivity in brain tissue by a refill kinetic method of transcranial ultrasonic perfusion imaging : a comparison with Doppler sonography
经颅超声灌注成像再填充动力学法定量评估脑组织脑血管反应性:与多普勒超声检查的比较
DOI: --
发表时间: 2005
期刊: Acta Neurochir 95(suppl)
影响因子: --
作者: [T.Shiogai, A.Morisaka, N.Takayasu, K.T.Mizuno, et al.]
通讯作者: et al.
Discrepancy between clinical and pathological diagnoses of CBD and PSP.
CBD 和 PSP 的临床和病理诊断之间的差异。
DOI: --
发表时间: 2005
期刊: J Neurol 252・6
影响因子: --
作者: [Mizuno T, Shiga K, Nakata Y, Nagura J, Nakase T, Ueda Y, Takanashi Y, Urasaki K, Oyamada Y, Fushiki S, Nishikawa J, Yasuhara M, Nakajima K, Nakagawa M.]
通讯作者: Nakagawa M.
DOI: 10.1016/j.autneu.2005.09.004
发表时间: 2005-12-30
期刊: AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL
影响因子: 2.7
作者: [Kuriyama, N, Mizuno, T, Nakagawa, M]
通讯作者: Nakagawa, M
DOI: 10.1007/s00415-005-0708-0
发表时间: 2005-05-01
期刊: JOURNAL OF NEUROLOGY
影响因子: 6
作者: [Shiga, K, Yamada, K, Nakagawa, M]
通讯作者: Nakagawa, M
Pathomechanism of cerebral small vessel induced by TGFβ1 signalling
  • 批准号:
    22591595
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.91万
  • 财政年份:
    2010
  • 负责人:
    MIZUNO Toshiki
  • 依托单位:
MOLECULAR EPIDEMIOLOGY OF APOLIPOPROTEIN E AND VITAMIN D RECEPTOR IN NORTHERN PART OF KYOTO PREFECTURE
  • 批准号:
    07670449
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $1.34万
  • 财政年份:
    1995
  • 负责人:
    MIZUNO Toshiki
  • 依托单位:
国内基金
海外基金
ROS介导的α-synuclein/KLF9/PRB信号轴调控子宫内膜异位症孕激素抵抗的分子机制研究
  • 批准号:
    2026JJ81255
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    冯力元
  • 依托单位:
天麻20C通过抑制α-Synuclein聚集二次成核动力学过程发挥帕金森病治疗特色的机制研究
  • 批准号:
    2025JJ60645
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    彭也
  • 依托单位:
新型 DMC 结构类似物抗帕金森病中α -synuclein 病理的作用机制研究
  • 批准号:
    Z24H250003
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    张云龙
  • 依托单位:
α-Synuclein 乳酸化修饰降低突触可塑性导致 POCD 的机制研究
  • 批准号:
    24ZR1457700
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    张辉
  • 依托单位: